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Increased cyclooxygenase-2 (COX-2) expression and PGE2 synthesis
have been shown to be prerequisites for renal renin release after Na
deprivation. To answer the question of whether EP4 receptor type of
PGE2 mediates renin regulation under a low-salt diet, we examined
renin regulation in EP4/, EP4/, and in wild-type mice treated
with EP4 receptor antagonist. After 2 wk of a low-salt diet (0.02%
wt/wt NaCl), EP4/ mice showed diminished Na excretion, un-
changed K excretion, and reduced Ca2 excretion. Diuresis and
plasma electrolytes remained unchanged. EP4/ exhibited a similar
attenuation of Na excretion; however, diuresis and K excretion
were enhanced, and plasma Na concentration was higher, whereas
plasma K concentration was lower compared with control diet.
There were no significant differences between EP4/ and EP4/
mice in blood pressure, creatinine clearance, and plasma antidiuretic
hormone (ADH) concentration. Following salt restriction, plasma
renin and aldosterone concentrations and kidney renin mRNA level
rose significantly in EP4/ but not in EP4/ and in wild-type mice
treated with EP4 antagonist ONO-AE3–208. In the latter two groups,
the low-salt diet caused a significantly greater rise in PGE2 excretion.
Furthermore, mRNA expression for COX-2 and PGE2 synthetic
activity was significantly greater in EP4/ than in EP4/ mice. We
conclude that low dietary salt intake induces expression of COX-2
followed by enhanced renal PGE2 synthesis, which stimulates the
renin-angiotensin-aldosterone system by activation of EP4 receptor.
Most likely, defects at the step of EP4 receptor block negative
feedback mechanisms on the renal COX system, leading to persis-
tently high PGE2 levels, diuresis, and K loss.
prostaglandins; prostanoid receptors; cyclooxygenase; renin-angioten-
sin-aldosterone system
ACTIVATION OF THE RENIN-ANGIOTENSIN -aldosterone-system (RAAS)
is an important physiological mechanism to counteract volume
depletion, such as that due to limited amounts of NaCl intake
or losses of blood or extracellular fluid volume. PGE2 repre-
sents a signaling molecule able to modulate RAAS. In general,
prostaglandins are important renal modulators for renal salt-
and water homeostasis and vascular tone and renal perfusion.
Prostaglandins are synthesized by the cyclooxygenase (COX)
pathway, and two isoforms of COX enzymes are known:
COX-1 and COX-2. COX-1 represents a housekeeping enzyme
expressed by virtually all types of tissue, whereas COX-2 is
undetectable in most cells and tissues, and expression is in-
duced by various stimuli, such as growth factors or cytokines
(34). Both COX isoforms are expressed by the kidney, with a
predominant occurrence in the renal inner medulla and lower
concentrations in the outer medulla and renal cortex (8), but the
specific roles of these isozymes in renal regulation have not
been clarified in detail. Many studies in rodents and man
indicate that COX-2 expression is an important requirement for
renin stimulation (7, 10, 38) and show that PGE2 exerts key
functions in the regulation of renal renin release (15, 33).
Application of a low-salt diet (14, 38, 39) and loop diuretics
(21) in mice and rats induces COX-2 expression in the MD,
which leads to prostaglandin synthesis and contributes to renin
secretion. That this mechanism holds also in humans has been
shown in volunteers receiving furosemide or a low-salt diet
(17), as well as in patients suffering from antenatal Bartter
syndrome (18), clinical settings that are associated with ele-
vated renal PGE2 formation and renin release. Consequently,
renal PGE2 synthesis, and thereby renin secretion, can be
blocked by nonspecific COX inhibitors, such as indometh-
acin, and also by specific COX-2 inhibitors in mice and man
(30, 36).
PGE2 signals via four different types of receptor, EP1–EP4
(26), which are expressed in renal tissue (see Ref. 2 for
review). The precise role of the different EP receptors in
modulating renin in vivo still remains elusive. We recently
observed, in isolated perfused kidneys of EP4-knockout mice that
the stimulation of renin release by PGE2 was significantly lower
compared with that in controls (33) and that in furosemide-treated
EP4/mice, the increase in renin activity was lower compared
with control mice (27). In support of these data on the regu-
lation of renin, we observed EP4 mRNA expression in glom-
eruli and in renin-secreting juxtaglomerular (JG) granular
(14) cells, as well as EP4 protein expression in preglomeru-
lar arterioles (5). These observations indicated that EP4
receptor is involved in PGE2-induced renin activity, at least
following pharmacologically induced salt and water loss.
Whether EP4 also plays a dominant role in more physiolog-
ically relevant states of variations in salt intake in vivo is
unknown. In the present study, we investigated the role of
the EP4 receptor in regulating renin release following ad-
ministration of a chronic low-salt diet to mice with targeted
deletion of EP4 and by the use of EP4-selective pharmaco-
logical tools.
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Animals. All experiments were performed with female mice aged
8–12 wk. C57BL/6 mice were obtained from Charles River Labora-
tories (Wilmington, MA). EP4/ and EP4/ mice were generated
as previously described (11), and mice were weaned at the age of 21
days. Genotypes of the mice were determined by PCR analysis using
specific oligonucleotides to the respective EP locus and the Neo
cassette. RT-PCR using RNA isolated from EP4/ kidneys revealed
no cycle threshold (Ct) value significantly different from the water
control. All knockout mice were backcrossed to C57BL/6 more than
10 times. Animals were kept under controlled conditions at an
ambient temperature of 21 1°C and a 12:12-h light-dark cycle. They
had free access to water and standard chow diet containing 0.9% NaCl
wt/wt (Altromin, Germany). In the low-salt studies, animals were fed
a diet containing 0.02% wt/wt NaCl (Altromin, Germany). The State
Agency Giessen approved all animal experiments, and the procedures
followed were in accordance with institutional guidelines.
Animal experiments. After obtaining basal values, animals received
a low-salt diet [0.02% NaCl wt/wt (Altromin, Germany)] for 14 days.
The animals had access to water ad libitum. On experimental day 12,
animals were placed in metabolic cages for 2 days to examine urine
output with free access to water and a low-salt diet. Urine was
collected for 24 h in a cooling device to prevent prostaglandins from
decay. Body weight and drinking volume were determined daily. For
plasma analysis of electrolyte levels, animals were anesthetized, and
blood samples were taken by cardiac heart puncture. Plasma was
separated and kept at 80°C until analysis. In urine samples, elec-
trolyte concentrations were quantified by flame photometry
(EFOX5053, Eppendorf), as reported previously (27). In experiments
using EP4 receptor antagonist ONO AE3–208, the drug was given in
the drinking water (1 mg/ml) for 14 days.
Measurement of plasma renin concentration. For determination of
plasma renin concentration (PRC), the ANG I produced was measured
by ultramicroassay (27). Five serial dilutions from the same plasma
sample were assayed in duplicate for all samples. Linearity over three
serial dilutions was required for a value to be accepted. Renin
concentrations were expressed in Goldblatt units compared with renin
standards from the National Institute for Biological Standards and
Control (Hertfordshire, UK).
Determination of mean arterial blood pressure in anesthetized
mice and systolic blood pressure in conscious mice. Mice were
anesthetized with pentobarbital sodium (50 g/kg ip) and placed on a
heated table at 37°C to maintain body temperature. Cannulas were
placed into the trachea to facilitate breathing and into the carotid
artery to measure systemic mean arterial pressure (Cardiomax-III;
Columbus Instruments; Columbus, OH), as described by Nüsing et al.
(27). Systolic blood pressure was determined in conscious mice using
a noninvasive computerized automated tail-cuff system (BP-2000;
Visitech Systems, Apex, NC). The animals were trained by placing
them in restrainers on a heated platform daily at 1:00 PM for three
consecutive days to get them accustomed to the procedure, followed
by additional measurements of systolic blood pressure and heart rate
on two consecutive days. They underwent five preliminary cycles and
a 10-cycle measurement, which each have a minimum of 6 out of 10
successful measurements. Mean values obtained on days 4 and 5 were
used for comparisons. Following recording of baseline measurements
under a control diet, animals obtained a low-salt diet for 14 days, and
blood pressure was recorded as before.
Determination of urinary PGE2. Urinary PGE2 concentration was
determined by PGE2 competitive Biotrek enzyme immunoassay sys-
tem (PGE2-EIA-kit) from Amersham Biosciences (Buckinghamshire,
UK). Urine excretion rates were calculated on the basis of daily
excretion.
Determination of vasopressin and aldosterone in plasma. Plasma
levels of vasopressin and aldosterone were measured by specific
enzyme immunoassays (Arg8-vasopressin EIA kit) from R&D Sys-
tems (Wiesbaden-Nordenstadt, Germany) and aldosterone EIA kit
from Enzo Life Sciences (Lörrach, Germany), according to the in-
structions of the suppliers.
Determination of plasma and urinary creatinine levels and electrolytes.
Plasma and urinary creatinine levels were determined using a creati-
nine kit from Randox Laboratories (Ardmore, UK), according to the
instructions of the supplier. Electrolytes were determined by flame
photometry, as described previously (27).
Immunoblotting. To obtain whole tissue extracts, kidneys were
homogenized in 50 mM Tris·HCl, 1% Triton X-100, pH 7.4, supple-
mented with protease inhibitor cocktail (Merck, Darmstadt, Germany)
using a Potter S homogenizer and sonification. Following a 30-min
centrifugation at 18,000 g and 4°C, the supernatant was removed.
Protein concentrations were determined by the bicinchoninic acid
method, according to the manufacturer’s protocol (Pierce, Rockford,
IL) using BSA as the protein standard. Samples of 50-g protein were
mixed with 4 Laemmli sample buffer (0.2 mM Tris·HCl, 20% SDS,
40% glycerol, 0.04% bromophenol blue, pH 6.8, 20% -mercapto-
ethanol) and heated for 10 min at 95°C. The samples were separated
on 15% polyacrylamide minigels and transferred to nitrocellulose
membranes (Protran, Whatmann, Dassel, Germany). The membranes
were blocked with 5% nonfat dry milk in PBS and incubated with the
primary antibodies. The following antibodies were used: anti-COX-1
and anti-COX-2 (Cayman Chemical, Ann Arbor, MI) diluted 1:150 in
5% nonfat dry milk in PBS, containing 0.1% Tween 20 and left
overnight at 4°C. After washing 3 times, membranes were incubated
with secondary horseradish peroxidase-labeled antibody, diluted
1:5,000 in 5% nonfat dry milk in PBS, containing 0.1% Tween 20 for
1 h at room temperature. An antibody against ERK-2 (Santa Cruz
Biotechnology, Santa Cruz, CA) was used to detect for equal loading,
as previously described (1). Immunodetected protein bands were
visualized with the ECL detection system, according to the instruc-
tions of the supplier (GE Healthcare, Freiburg, Germany). Densito-
metric analysis was performed using ImageJ software (National In-
stitutes of Health).
Quantitative real-time PCR. Kidneys from mice were dissected and
stored at80°C until analysis. Total RNA was isolated using RNeasy
kit (Qiagen, Hilden, Germany), according to the manufacturer’s in-
structions. The RNA concentration was quantified by A260 using a
NanoDrop spectrophotometer (Peqlab Biotechnologie, Erlangen, Ger-
many). 0.5 g RNA was reverse transcribed using superscript II
RNase and random hexamers (Invitrogen, Karlsruhe, Germany), and
1/40 volumes of the resulting cDNA samples were used as templates
for real-time PCR using SYBR Green supermix reaction procedure
with the 7500 Fast System (Applied Biosystems, Darmstadt, Ger-
many). All reactions were run in triplicate to minimize experimental
error. The following primer pairs were used: for COX-1, GTG GCT
ATT TCC TGC AGC TC and CAG TGC CTC AAC CCC ATA GT;
for COX-2, GCA GTT GTT CCA GAC AAG CA and AAG GGG
ATG CCA GTG ATA GA; for renin, ATG AAG GGG GTG TCT
GTG GGG AND ATG TCG GGG AGG GTG GGC ACC TG; and for
-actin, TCC ATC ATG AAG TGT GAC GT and GAG CAA TGA
TCT TGA TCT TCA T. PCR was initiated at 95°C for 15 min
followed by 40 cycles of 15 s at 95°C, and 1 min at 60°C for annealing
and extension. As an internal control, we used 18S-rRNA (32). The
expression of mRNA was assessed relative to that of -actin, and the
relative quantitative level of samples was determined by the standard
2 (ddCt) method and expressed as change (fold) relative to expression
levels under control condition.
Assay for PGE2 synthetic activity. For determination of PGE2
synthesis, kidneys were weighed and rapidly homogenized in 2 vol
(wt/vol) of cold tissue-buffer (50 mM Tris pH 7.4, 1 mM phenol, 1
protease inhibitor cocktail set; Merck Chemicals, Darmstadt, Ger-
many) with an ultraturax followed by ultrasonification (5–10 for
2–4 s). Homogenates were centrifuged for 10 min at 3,000 g, and
protein concentration of the supernatants was determined. Samples of
100 g protein were prewarmed at 37°C for 1 min, and reactions were
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started by the addition of 50 M arachidonic acid. After 10-min
incubation, the reaction was stopped with 1% formic acid, PGE2 was
extracted and determined by LC-MS/MS, as described previously
(31). In brief, for liquid-liquid-extraction, samples were incubated
twice with 600 l ethylacetate, and the organic phase was removed at
45°C under nitrogen. For reconstitution, 50 l of acetonitrile/water/
formic acid (20:80:0.0025, vol/vol, pH 4.0) was used and after
centrifugation for 5 min at 18,000 g, samples were used for injection.
PGE2 was separated with a Synergi 150  2 mm Hydro-RP column
(Phenomenex, Aschaffenburg, Germany) and determined with an API
4000 triple quadrupole mass spectrometer (AB Sciex, Darmstadt,
Germany).
Statistical analysis. Normality was determined by the D’Agostino-
Pearson test. Data are presented as means  SE. Analyses were
performed by ANOVA and post hoc Bonferroni’s multiple-compari-
son test for all groups or unpaired t-test for two-group comparison.
Prism 5.0 software (GraphPad, San Diego, CA) was used for all
calculations. A P value 0.05 was considered significant.
RESULTS
EP4/ control mice and EP4/ mice were fed for 14 days
with a low-salt diet containing 0.02% NaCl. Analysis of blood
electrolytes (Table 1) revealed that in control mice, Na, K,
and Ca2 concentrations remained unchanged under a low-salt
diet compared with a normal diet. In EP4/ mice, low-salt
conditions caused a slight, but significant, increase in plasma
Na and a significant decrease in K concentration, whereas
blood Ca2 remained unchanged. Following salt restriction, di-
uresis was not affected in control mice. However, EP4/ mice
exhibited a significant higher output of urine volume (Fig. 1A).
With regard to excretion rates of the electrolytes, Na declined
by 85% (Fig. 1B), K remained unchanged (Fig. 1C) and Ca2
decreased by 40% in control mice on a low-salt intake. In
EP4/ mice, we observed that daily Na excretion was also
dramatically diminished by about 86% under a low-salt diet
(Fig. 1B). However, potassium excretion was significantly
higher compared with that under control conditions (Fig.
1C). The excretion rate of calcium did not differ before or
after salt restriction (Fig. 1D).
Calculation of creatinine clearance, using plasma and urine
creatinine levels, revealed no differences in either control mice
or EP4/ mice under our experimental conditions (Fig. 2A).
In EP4/ and in EP4/ mice, there was a tendency that
plasma concentrations of antidiuretic hormone were enhanced
following a low-salt diet, but this did not reach statistical
significance (Fig. 2B). Mean arterial pressure in anesthetized
mice was not significantly different between EP4/, EP4/,
and wild-type mice treated with EP4 antagonist ONO AE3–
208 (Fig. 2C). Furthermore, systolic blood pressure as mea-
Table 1. Blood electrolytes in wild-type and EP4 receptor
knockout mice under basal conditions and after a low-salt
diet for 14 days
Na, mmol/l K, mmol/l Ca2, mmol/l
c ls c ls c ls
WT 147.3 147.3 5.23 4.79 1.47 1.33
 0.3  0.6  0.29  0.38  0.02  0.06
EP4/ 147.1 150.6* 5.10 4.07* 1.31 1.34
 0.6  0.9  0.16  0.17  0.04  0.03
Values are expressed as means  SE (n 	 12–14). c, control; ls, low salt,
WT, wild type. *Significant difference (P 0.05) between the c and ls groups.
Fig. 1. Urine volume (A), sodium excretion (B),
potassium excretion (C), and calcium excretion (D)
in EP4/ and EP4/ mice under normal diet (c)
and low salt diet (ls) conditions. Following 14 days
on a control diet or under salt restriction, animals
were placed in metabolic cages and 24-h urine
collection was performed. Data are expressed as
means  SE. *Significant difference, P  0.05
between the indicated groups (n 	 12).
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sured by the tail-cuff method in conscious EP4/ and EP4/
mice showed also no difference , neither under the control diet nor
under a low-salt diet (Fig. 2D). Interestingly, compared with
EP4/, heart rate of EP4/ mice was significantly lower under
a control diet, but not under a low-salt diet (Fig. 2E).
In a subsequent set of experiments, we studied the role of the
EP4 receptor in activating renin and aldosterone, two compo-
nents of the RAAS. In EP4/ mice, salt restriction caused a
significant rise in plasma renin concentration (Fig. 3A). In
striking contrast, no significant difference was observed in
EP4/ mice and also not in C57BL6 wild-type mice treated
with EP4 antagonist ONO AE3–208 (Fig. 3A). Analysis of
renin mRNA by real-time PCR methodology revealed an
increase in renin mRNA expression following a low-salt diet
only in EP4/ mice (Fig. 3B). Neither in EP4/ nor in
wild-type mice treated with EP4 antagonist was a significant
change in renin mRNA expression observed. With regard to
plasma aldosterone concentrations, we observed a significant
rise following a low-salt diet in EP4/ mice but not in mice
deficient in EP4 receptor function, achieved either by knockout
or by pharmacological blockade (Fig. 3C).
We determined 6-keto-PGF1
 and TXB2, the more stable
hydrolyzation products of PGI2 and TXB2, respectively, and
PGE2 in urine samples by enzyme immunoassay to calculate
daily prostanoid excretion under normal and low-salt diet
conditions. In EP4/ and EP4/ mice, a low-salt diet for 14
days caused a significant increase in the urinary PGE2 excre-
tion rate, but the increases were significantly different between
both groups. In EP4/ mice, salt restriction caused an in-
crease of PGE2 excretion of 220% compared with the normal
diet, whereas the urinary PGE2 excretion in EP4/ mice was
enhanced by about 650%, a significant augmentation compared
Fig. 2. Creatinine clearance (A), plasma ADH
concentration (B), mean arterial pressure in
anesthetized (C) EP4/ and EP4/ mice
and systolic blood pressure (D) and heart rate
(E) in conscious EP4/ and EP4/ mice
under normal diet (c) and low-salt-diet (ls)
conditions. Following 14 days of salt restric-
tion, animals were placed in metabolic cages,
and 24-h urine collection was performed.
Mice were killed, and blood was taken. Cre-
atinine was determined in urine, and plasma
samples and clearance were calculated (n 	
12). ADH in plasma was determined by EIA
(n 	 12). Mean arterial pressure was deter-
mined in anesthetized mice (n 	 6). Systolic
blood pressure in conscious mice was deter-
mined by noninvasive tail-cuff method (n 	
6). Data are expressed as means SE, and no
significant differences between the groups
were found, except for heart rate in EP4/
compared with EP4/ under control diet.
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with that in EP4/ mice (Fig. 4A). Excretion rates for 6-keto-
PGF1
 and TXB2 did not differ between the experimental
groups (Fig. 4, B and C).
To investigate the COX isoform responsible for the in-
crease in PGE2 excretion, we analyzed renal expression of
protein and mRNA for COX-1 and COX-2 by Western blot
analysis and quantitative real-time PCR. In kidneys from
EP4/ and EP4/ mice, we observed a significant increase
in the COX-2 protein but not of COX-1 (Fig. 5, A and B) after
14 days on a low-salt diet. Of note, induction of COX-2 protein
in EP4/ was more pronounced compared with EP4/ mice.
In both mouse lines, a tendency toward an increase in COX-1
mRNA expression was observed, which did not achieve sta-
tistical significance. In contrast, COX-2 mRNA expression was
significantly induced by a low-salt diet in EP4/ and EP4/
mice, and the induction of COX-2 mRNA expression was also
significantly higher in EP4/ mice than in control mice (Fig.
5C). To investigate whether changes in COX-2 expression
were paralleled by changes in renal PGE2 synthetic capacity,
we measured PGE2 formed by kidney tissue homogenates from
EP4/ and EP4/ mice on a control and a low-salt diet
following the addition of exogenous arachidonic acid. Under a
low-salt diet, significantly elevated PGE2-synthesizing activi-
ties were observed in both groups (Fig. 5D), whereas PGE2
synthesis was significantly higher in the EP4/ group.
DISCUSSION
The purpose of our study was to determine the relevance of
PGE2 receptor subtype EP4 for the regulation of the RAAS by
salt restriction in vivo. Our findings demonstrate that salt
restriction involves COX-2 induction, enhanced PGE2 release,
and requirement for the PGE2 receptor type EP4 for RAAS
activation. Abolition of the signaling system through the EP4
receptor not only attenuates RAAS activation but also blocks
negative feedback mechanisms on the COX system, leading to
overstimulated COX-2 expression and PGE2 synthesis, thereby
contributing to further electrolyte alterations, such as raised
urine and potassium output.
In general, loss of NaCl and water and, hence, extracellular
fluid volume activates the RAAS to counteract volume deple-
tion. The juxtaglomerular apparatus senses the luminal NaCl
concentration in the area of the macula densa (9), involving the
Na-K-2Cl cotransporter, NKCC2. A decrease in luminal salt
concentration and in plasma volume stimulates renin release.
The activation of the RAAS leads to NaCl and water retention
and maintenance of blood pressure. The role of COX isoen-
zymes in this type of macula densa-dependent RAAS regula-
tion is not clear. On the one hand, in rats, abolition of
COX-1-derived rather than COX-2-derived PGE2 suppressed
the stimulation of the renin system by low-salt intake (12), and
COX-2 inhibition does not attenuate relative responses of the
renin system following a low-salt diet (22). On the other hand,
several studies indicate that induction of COX-2 and enhanced
PGE2 synthesis are key steps leading to renin secretion as the
first step in RAAS activation. Salt deprivation in mice causes
induction of COX-2 in the macula densa accompanied by an
increase in renal PGE2 formation prior to renin secretion (10,
13, 39). Treatment with coxibs can diminish stimulation of the
RAAS following a low-salt diet (6) and in experiments with
COX-2 knockout mice, significantly attenuated increase in
renin mRNA expression, and renin activity was observed
compared with wild-type mice following a low-salt diet (38).
In the present study, low-salt intake was associated with an
induction of COX-2 at the mRNA and protein levels and an
increase in renal PGE2 synthesis. These data led us to assume
that COX-2 may be involved in salt-dependent regulation of
renin.
Although the importance of COX-2 expression and PGE2
formation for renin release has been emphasized, the PGE2-
Fig. 3. Plasma renin concentration (A), renin mRNA expression (B), and
plasma aldosterone concentration (C) in EP4/, EP4/ mice and in C57BL6
wild-type mice treated with the EP4 antagonist ONO AE3–208 (WTEP4A)
under normal diet (c) and low-salt diet (ls) conditions. Following 14 days of
control diet or salt restriction, in the absence or presence of EP4 antagonist,
animals were killed, and plasma was prepared for renin and aldosterone
determination. Kidneys were removed for RNA isolation and quantitative
real-time PCR. Data are expressed as means  SE; n 	 5–10. *P  0.05
compared with control. #P  0,05 compared with EP4/ low-salt group.
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dependent signaling pathway, has not been clarified in vivo.
Four types of PGE2 receptors, EP1 to EP4, are expressed
within the kidney (3, 14, 16, 24), and coupling to distinct renal
functions has been suggested. Experiments using furosemide to
block NaCl reabsorption by NKCC2 have shown that PGE2
mainly signals via the EP4 receptor to activate the RAAS in
mice (4, 27). In the present study, we show that enhanced
plasma renin and aldosterone concentrations following salt
restriction were also dependent on EP4 receptor function. In
EP4/ mice, a low-salt diet for 14 days did not stimulate
plasma renin activity, renin mRNA expression, or plasma
aldosterone concentration. Strong support for the role of the
EP4 receptor in salt-dependent renin regulation came from our
experiments using the selective EP4 receptor antagonist, ONO-
AE3–208, in wild-type mice. Similar to targeted gene disrup-
tion, pharmacological blockade leads to suppression of renin
Fig. 4. Urinary PGE2 (A), 6-kto-PGF1
 (B), and TXB2 (C) excretion by EP4/ mice and EP4/ mice under normal diet (c) and low-salt diet (ls) conditions.
Following 14 days of salt restriction, animals were placed in metabolic cages, and 24-h urine collection was performed. Prostanoid concentrations in urine
samples were determined by EIAs. Data are expressed as means SE; n	 10–12. *P 0.05 compared with control. #P 0.05 compared with EP4/ low-salt
group.
Fig. 5. Expression of COX-1 and COX-2 protein (A
and B) and mRNA (C) by EP4/ mice and EP4/
mice under normal diet (c) and low-salt diet (ls)
conditions, and PGE2 synthetic activity (D). Follow-
ing 14 days of a control diet or salt restriction,
animals were killed and kidneys were removed. COX
mRNA expression was analyzed by real-time PCR
and COX protein expression by Western blot analy-
sis. Relative expression to ERK-2 is presented for at
least three independent experiments. For determina-
tion of PGE2 synthetic activity, kidney homogenates
were prepared and incubated with arachidonic acid.
Formed PGE2 was determined by LS-MS/MS. Data
are expressed as means  SE; n 	 4. *P  0.05
compared with control; #P  0.05 compared with
EP4/ low-salt group.
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activity, renin expression, and aldosterone level. Several hints
support our observation on the role of EP4 receptor as the type
of PGE2 receptor responsible for coupling alterations in salt
intake to renin secretion. First, the EP4 receptor is coupled to
intracellular cAMP elevation, which is known to be an essen-
tial prerequisite for renin secretion (19), and in isolated juxta-
glomerular apparatus cells, a selective EP4 agonist led to a
rapid cAMP formation and renin secretion (5). Second, renin
secretion rates stimulated by PGE2 are strongly attenuated in
isolated, perfused kidneys from EP4/ mice (33). Third, the
EP4 receptor is expressed in renin-secreting juxtaglomerular
granular cells (5), and EP4 transcripts were increased twofold
by salt deprivation (14). Fourth, activation of renin activity by
furosemide also depends on the EP4 receptor (4, 27). Although
we cannot exclude a role of the EP2 receptor type, which is
also coupled to intracellular cAMP elevation, a predominant
role of this receptor is unlikely, as EP2 was found to be
expressed in the kidney medulla. Furthermore, EP2 receptor
deficiency exerts no significant effect on furosemide-induced
renin activity (4, 27). Regarding the juxtaglomerular expres-
sion of EP4 receptor, a direct effect of PGE2 on JG cells via
EP4 to secrete renin is assumed; however, our data do not
exclude the possibility that other EP4-expressing cell types are
involved.
Aldosterone secretion is enhanced by ANG II, ACTH, and
increased plasma potassium concentration (20). Because plasma
ANG II likely mirrors suppressed renin concentration in
EP4/ and plasma K concentration is also lower following
salt restriction, both of these factors probably contribute to the
observed lower plasma aldosterone concentration in EP4-de-
leted mice compared with wild-type mice. In addition, a recent
report indicated that EP4 receptor directly enhances aldoste-
rone secretion from zona glomerulosa cells (25). Therefore,
blockade of the EP4 receptor could also contribute to lower
aldosterone plasma concentrations in EP4/ mice. Na ex-
cretion was not different in EP4/ mice, and blood pressure
was not altered by a low-salt diet. Therefore, other mecha-
nisms, e.g., sympathetic nervous system, medullary blood flow,
or vasopressin (23), as recently recognized, independent of
RAAS must be operating in the nephron to enhance salt
reabsorption and to maintain salt balance and blood pressure in
EP4/ mice. Further studies are necessary to address the
identification of such a compensatory mechanism and whether
this may be operable only in mice, which are known for their
great ability to reabsorb salt under low-salt conditions or also
in other species, such as in rat or man.
Interestingly, under a low-salt diet, urinary PGE2 excretion
rate was significantly higher in EP4-deficient mice than in
control mice. We speculate that because of genetic or pharma-
cological abolition of EP4 function, negative feedback mech-
anisms are disrupted leading to overexpressed renal COX-2
and PGE2 synthesis. As we did not observe a significant
difference in COX-2 expression under normal salt diet in
EP4/ and EP4/ mice, we assume that higher PGE2 levels
are necessary to trigger the negative feedback mechanism. We
can only speculate on the mechanisms involved, but the most
likely candidates are ANG II and aldosterone. On the one hand,
an indirect negative feedback control of the renin system by
ANG II is possible. ACE inhibition and AT1-receptor blockade
lead to a rise in renin and COX-2 expression in rats (37) and
chronic infusion of ANG II attenuated cortical COX-2 expres-
sion (41). Moreover, in the cultured macula densa cell line,
MMDD1, ANG II inhibited COX-2 expression (41). On the
other hand, mineralocorticoids have been shown to be the
dominant adrenal steroids regulating expression of COX-2 in
the renal cortex. In mature rats, adrenalectomy causes an
increase in COX-2 expression in the cortical thick ascending
limb and most dramatic in macula densa (40). Administration
of the aldosterone analog, DOCA, to adrenalectomized rats
suppressed COX-2 expression to undetectable levels (40).
Further studies are necessary to clarify the negative feedback
mechanisms of the renin system.
In control mice, a low-salt diet caused activation of the
RAAS with an elevation in renin activity, renin mRNA expres-
sion, and increased plasma aldosterone concentration. Conse-
quently, Na excretion was reduced by 90%, whereas K
excretion was unaffected, and the plasma concentrations of
electrolytes were constant. In salt-restricted EP4/ mice, Na
excretion was diminished to a similar extent as in EP4/
mice, but diuresis was enhanced, plasma Na and daily K
excretion increased, and plasma K concentration was re-
duced. Alterations in glomerular filtraton rate (GFR) or in
ADH concentrations appear not to be responsible for this
difference, although, high PGE2 levels most likely contributed
to the small, but insignificant, increase in GFR in EP4/, as
well as in EP4/. In both mouse groups, salt restriction
caused minimal, but nonsignificant, increases in plasma ADH
concentration. The reason for the increased diuresis in salt-
restricted EP4/ mice could have been increased activation of
AVP-antagonizing EP1/EP3 receptors in the collecting duct
system due to strongly elevated PGE2 levels or, alternatively,
to lack of an EP4 receptor-mediated effect in promoting water
reabsorption in the collecting ducts. Very recently, it has been
shown that EP4 agonist CAY10580 is able to increase traffick-
ing of AQP2 in the collecting duct cell line MDCK, indepen-
dent of vasopressin (28). Thus, it appears possible that EP4
receptor deficiency under certain circumstances favors water
loss, and the small increase in GFR as observed in our study,
may have fostered a rise in diuresis. Interestingly, potassium
excretion significantly increased in EP4/ mice due to the
low-salt diet, which was reflected in a lowered plasma K
concentration. In control mice, no diet-dependent differences
were observed. Most likely, a rise in distal flow provokes
flow-mediated K secretion, a well-known phenomenon, in
which large-conductance voltage, Ca2-activated K (BK)
channels are involved (29). A direct modulatory role on BK
channels in the action of PGE2 is unlikely, as cyclooxygenase
inhibitors do not blunt arachidonic acid-induced activation of
BK channels in the collecting duct system (35).
In summary, we conclude that the PGE2 receptor type EP4
is necessary for stimulation of the RAAS in response to a
low-salt condition in vivo, a condition that has been the
predominant evolutionary challenge.
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